IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 1.550
-0.050 (-3.13%)
Mar 9, 2026, 4:46 PM CET
IRLAB Therapeutics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 81.86 | 66.92 | 111.31 | 252.78 | 401.9 | Upgrade
|
| Cash & Short-Term Investments | 81.86 | 66.92 | 111.31 | 252.78 | 401.9 | Upgrade
|
| Cash Growth | 22.33% | -39.88% | -55.96% | -37.10% | 45.08% | Upgrade
|
| Accounts Receivable | 4.01 | - | - | 3.32 | 4.47 | Upgrade
|
| Other Receivables | - | 10.08 | 9.17 | 8.9 | 6.27 | Upgrade
|
| Receivables | 4.01 | 10.08 | 9.17 | 12.22 | 10.74 | Upgrade
|
| Prepaid Expenses | - | 2.2 | 2.8 | 3.34 | 2.28 | Upgrade
|
| Other Current Assets | -0 | 0.37 | 0.31 | 0.35 | 6.52 | Upgrade
|
| Total Current Assets | 85.87 | 79.56 | 123.59 | 268.68 | 421.44 | Upgrade
|
| Property, Plant & Equipment | 5.47 | 9.79 | 6.67 | 8.01 | 8.35 | Upgrade
|
| Other Intangible Assets | 46.86 | 46.86 | 46.86 | 46.86 | 42.4 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.26 | Upgrade
|
| Other Long-Term Assets | - | -0 | - | -0 | -0 | Upgrade
|
| Total Assets | 138.21 | 136.21 | 177.12 | 323.56 | 472.45 | Upgrade
|
| Accounts Payable | - | 9.94 | 10.52 | 10.03 | 12.3 | Upgrade
|
| Accrued Expenses | - | 11.68 | 14.91 | 13.44 | 5.84 | Upgrade
|
| Short-Term Debt | 26.42 | 53.47 | - | - | - | Upgrade
|
| Current Portion of Leases | 3.54 | 3.42 | 2.94 | 3.6 | 3.03 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 42.58 | Upgrade
|
| Other Current Liabilities | 77.54 | 21.54 | 8.35 | 5.28 | 5.65 | Upgrade
|
| Total Current Liabilities | 107.49 | 100.04 | 36.73 | 32.34 | 69.4 | Upgrade
|
| Long-Term Debt | - | - | 24.51 | - | - | Upgrade
|
| Long-Term Leases | - | 3.54 | 0.12 | 0.38 | 3.57 | Upgrade
|
| Total Liabilities | 107.49 | 103.58 | 61.36 | 32.72 | 72.97 | Upgrade
|
| Common Stock | 1.7 | 1.04 | 1.04 | 1.04 | 1.04 | Upgrade
|
| Additional Paid-In Capital | 800.41 | 690.21 | 690.21 | 690.21 | 685.45 | Upgrade
|
| Retained Earnings | -771.39 | -658.61 | -575.48 | -400.41 | -287 | Upgrade
|
| Comprehensive Income & Other | - | 0 | - | - | - | Upgrade
|
| Shareholders' Equity | 30.72 | 32.64 | 115.76 | 290.83 | 399.48 | Upgrade
|
| Total Liabilities & Equity | 138.21 | 136.21 | 177.12 | 323.56 | 472.45 | Upgrade
|
| Total Debt | 29.95 | 60.42 | 27.57 | 3.98 | 6.6 | Upgrade
|
| Net Cash (Debt) | 51.91 | 6.5 | 83.74 | 248.8 | 395.3 | Upgrade
|
| Net Cash Growth | 699.06% | -92.24% | -66.34% | -37.06% | 44.23% | Upgrade
|
| Net Cash Per Share | 0.77 | 0.13 | 1.61 | 4.80 | 7.64 | Upgrade
|
| Filing Date Shares Outstanding | 84.94 | 51.87 | 51.87 | 51.87 | 51.75 | Upgrade
|
| Total Common Shares Outstanding | 84.94 | 51.87 | 51.87 | 51.87 | 51.75 | Upgrade
|
| Working Capital | -21.62 | -20.48 | 86.86 | 236.34 | 352.04 | Upgrade
|
| Book Value Per Share | 0.36 | 0.63 | 2.23 | 5.61 | 7.72 | Upgrade
|
| Tangible Book Value | -16.14 | -14.23 | 68.9 | 243.97 | 357.08 | Upgrade
|
| Tangible Book Value Per Share | -0.19 | -0.27 | 1.33 | 4.70 | 6.90 | Upgrade
|
| Machinery | - | 7.02 | 6.82 | 6.53 | 3.65 | Upgrade
|
| Leasehold Improvements | - | 0.12 | 0.12 | 0.12 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.